Developing a Decision Support Tool for Multiple Sclerosis Prognosis
Author Information
Author(s): Martin Daumer, Anneke Neuhaus, Christian Lederer, Michael Scholz, Jerry Wolinsky, Marc Heiderhoff
Primary Institution: Sylvia Lawry Centre for Multiple Sclerosis Research
Hypothesis
Can an online analytical processing tool improve the prediction of disease progression in multiple sclerosis patients?
Conclusion
The OLAP tool can help physicians and researchers model the disease course for multiple sclerosis patients based on existing clinical trial data.
Supporting Evidence
- The OLAP tool uses a database of 1,059 patients from clinical trials to model disease progression.
- The tool allows real-time statistical analysis based on patient characteristics.
- Kaplan-Meier curves are used to display time to disease progression.
Takeaway
This study created a computer tool that helps doctors predict how multiple sclerosis will affect their patients by looking at similar cases.
Methodology
The study used a matching algorithm to select similar patients from a database of clinical trial data to predict disease progression.
Potential Biases
The data is restricted to placebo groups in clinical trials, which may not reflect real-world outcomes.
Limitations
The predictive power is limited by the composition of patients in the database and the maximum observation period of 3 years.
Participant Demographics
The database includes data from 1,059 patients with various forms of multiple sclerosis, primarily from clinical trials.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website